

NEW YORK  Dec 12 (Reuters) - Synta Pharmaceuticals Corp
 :
 * Pharma up 10.8 percent to $5.15 in premarket after interim
results from ganetespib trial 


FILED UNDER:   
http://feeds.reuters.com/~r/reuters/companyNews/~3/N20KY1u5dXc/story01.htm